The diabetes drug Janumet, which combines Januvia and Metformin, has helped millions of patients control the high blood sugar associated with type-2 diabetes since it was released in 2007. It has also become one of the best-selling drugs for pharmaceutical giant Merck & Co.
Unfortunately, health experts have now discovered a link between Janumet and pancreatic cancer that may place patients at risk.
The FDA, American Medical Association, Institute for Safe Medication Practices and UCLA have all warned that drugs containing sitagliptin, such as Januvia and Janumet, may be linked to pancreatitis, a major risk factor for Janumet pancreatic cancer.
Pancreatic cancer is a severe condition that attacks the lining of the pancreas. It is often detected late, can spread quickly, and is a leading cause of cancer death. Janumet and pancreatic cancer may be related due to the drug’s inhibition of enzymes that guard the body against cancer cells.
Some of the common symptoms of Janumet pancreatic cancer include:
If you have experienced any of these symptoms, it is important to speak with your doctor immediately. If pancreatic cancer is diagnosed, it is also important to learn about your legal rights.
Lawyers are currently helping those affected file claims against Merck due to the company’s failure to properly warn patients about the risks of Janumet pancreatic cancer. You may be entitled to compensation.
If you or a family member were diagnosed with pancreatic cancer after taking Janumet, it is important to speak with a lawyer about your legal rights as soon as possible. Time to file a claim is limited. Contact us today.
The first link between Janumet and pancreatic cancer came in 2009, when the FDA warned that diabetes drugs like Januvia and Janumet could increase risks for pancreatitis, a contributing factor for pancreatic cancer.
That year, the FDA ordered Merck to conduct new safety tests on the drug. However, a violation letter sent in 2012 shows they were still delaying testing.
In 2011, researchers at UCLA discovered drugs like Janumet may be linked to a 270% increased rate of pancreatic cancer.
This year, both the Journal for the American Medical Association and Institute for Safe Medication Practices have warned of Janumet pancreatic cancer risks, showing that the rate of pancreatitis and pre-cancerous cells may be higher from these types of drugs.
A lawyer can explain the research linking Janumet and pancreatic cancer, as well as how the delay of testing and warnings from Merck may have affected patients. If you or a family member have been affected, they can discuss your case today at no cost.
Lawsuits for defective drug injuries can be very complex. Therefore, it is important to choose a lawyer with experience in this type of case. DrugRisk only recommends lawyers and law firms that have already handled diabetes drug cancer or Janumet lawsuits.
Contact us today for more information on the warnings, research, side effects and legal news related to Janumet and other diabetes drugs, or to speak with a lawyer. We are available 24 hours a day to help.